Gene expression patterns combined with bioinformatics analysis identify genes associated with cholangiocarcinoma

To explore the molecular mechanisms of cholangiocarcinoma (CC), microarray technology was used to find biomarkers for early detection and diagnosis. The gene expression profiles from 6 patients with CC and 5 normal controls were downloaded from Gene Expression Omnibus and compared. As a result, 204 differentially co-expressed genes (DCGs) in CC patients compared to normal controls were identified using a computational bioinformatics analysis. These genes were mainly involved in coenzyme metabolic process, peptidase activity and oxidation reduction. A regulatory network was constructed by mapping the DCGs to known regulation data. Four transcription factors, FOXC1, ZIC2, NKX2-2 and GCGR, were hub nodes in the network. In conclusion, this study provides a set of targets useful for future investigations into molecular biomarker studies.

[1]  In-Sun Chu,et al.  Genome-wide expression patterns associated with oncogenesis and sarcomatous transdifferentation of cholangiocarcinoma , 2011, BMC Cancer.

[2]  Young Bae Kim,et al.  A fibrous stromal component in hepatocellular carcinoma reveals a cholangiocarcinoma‐like gene expression trait and epithelial‐mesenchymal transition , 2012, Hepatology.

[3]  S. Thorgeirsson,et al.  Genetic profiling of intrahepatic cholangiocarcinoma , 2012, Current opinion in gastroenterology.

[4]  Masanao Miwa,et al.  Hepatitis viruses and risk of cholangiocarcinoma in northeast Thailand. , 2010, Asian Pacific journal of cancer prevention : APJCP.

[5]  Luigi Tornillo,et al.  Galectin-1 and Its Involvement in Hepatocellular Carcinoma Aggressiveness , 2010, Molecular medicine.

[6]  J. Carl Barrett,et al.  Prediction of Lymph Node Metastasis in Patients with Endometrioid Endometrial Cancer Using Expression Microarray , 2006, Clinical Cancer Research.

[7]  Yongyong Shi,et al.  Retraction Note to: Comparison of hepatocellular carcinoma (HCC), cholangiocarcinoma (CC), and combined HCC-CC (CHC) with each other based on microarray dataset , 2013, Tumor Biology.

[8]  Satya vani Guttula,et al.  Analyzing Microarray Data of Alzheimer's Using Cluster Analysis to Identify the Biomarker Genes , 2012, International journal of Alzheimer's disease.

[9]  Robert S Warren,et al.  Homeodomain transcription factor NKX2.2 functions in immature cells to control enteroendocrine differentiation and is expressed in gastrointestinal neuroendocrine tumors. , 2008, Endocrine-related cancer.

[10]  Hui Yu,et al.  Bioinformatics Applications Note Gene Expression Dcgl: an R Package for Identifying Differentially Coexpressed Genes and Links from Gene Expression Microarray Data , 2022 .

[11]  A. Giuliano,et al.  FOXC1 is a potential prognostic biomarker with functional significance in basal-like breast cancer. , 2010, Cancer research.

[12]  Santosh B Reddy,et al.  Current approaches to the diagnosis and treatment of cholangiocarcinoma , 2006, Current gastroenterology reports.

[13]  D. M. Lloyd,et al.  Elevation of Carbohydrate Antigen 19.9 in Benign Hepatobiliary Conditions and Its Correlation with Serum Bilirubin Concentration , 2008, Digestive Diseases and Sciences.

[14]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[15]  Erik Schrumpf,et al.  Novel target genes and a valid biomarker panel identified for cholangiocarcinoma , 2012, Epigenetics.

[16]  Stephen L. Lessnick,et al.  EWS/FLI Mediates Transcriptional Repression via NKX2.2 during Oncogenic Transformation in Ewing's Sarcoma , 2008, PloS one.

[17]  D. Rice,et al.  Foxc1 integrates Fgf and Bmp signalling independently of twist or noggin during calvarial bone development , 2005, Developmental dynamics : an official publication of the American Association of Anatomists.

[18]  H Sugimura,et al.  Predominant expression of human zic in cerebellar granule cell lineage and medulloblastoma. , 1996, Cancer research.

[19]  G. Gores,et al.  Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment , 2008, Hepatology.

[20]  Partha S. Ray,et al.  Basal-Like Breast Cancer Defined by FOXC1 Expression Offers Superior Prognostic Value: A Retrospective Immunohistochemical Study , 2011, Annals of Surgical Oncology.

[21]  Yongyong Shi,et al.  RETRACTED ARTICLE: Comparison of hepatocellular carcinoma (HCC), cholangiocarcinoma (CC), and combined HCC-CC (CHC) with each other based on microarray dataset , 2013, Tumor Biology.

[22]  최진섭,et al.  A fibrous stromal component in hepatocellular carcinoma reveals a cholangiocarcinoma-like gene expression trait and epithelial-mesenchymal transition. , 2012 .

[23]  Christa S Merzdorf,et al.  Emerging roles for zic genes in early development , 2007, Developmental dynamics : an official publication of the American Association of Anatomists.

[24]  S. Glaser,et al.  Mechanisms of biliary carcinogenesis and growth. , 2008, World journal of gastroenterology.

[25]  M. Roizen,et al.  Hallmarks of Cancer: The Next Generation , 2012 .

[26]  D. Duboule,et al.  Regional expression of the homeobox gene Nkx-2.2 in the developing mammalian forebrain , 1992, Neuron.

[27]  T. Ørntoft,et al.  Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population. , 1999, Clinical chemistry.

[28]  Martine Prévost,et al.  Mutational and Cysteine Scanning Analysis of the Glucagon Receptor N-terminal Domain* , 2010, The Journal of Biological Chemistry.

[29]  N V Kharchenko,et al.  [Current approaches to the diagnosis and treatment of irritable bowel syndrome]. , 2001, Likars'ka sprava.

[30]  Alphonse E. Sirica,et al.  Cholangiocarcinoma: Molecular targeting strategies for chemoprevention and therapy , 2005, Hepatology.

[31]  M. Goggins.  Molecular markers of early pancreatic cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  D. Jäger,et al.  Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Joshua M. Stuart,et al.  A Gene-Coexpression Network for Global Discovery of Conserved Genetic Modules , 2003, Science.

[34]  T. Golub,et al.  Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma. , 2006, Cancer cell.

[35]  B. E. Van Beers,et al.  Diagnosis of cholangiocarcinoma. , 2008 .

[36]  S. Bergmann,et al.  Similarities and Differences in Genome-Wide Expression Data of Six Organisms , 2003, PLoS biology.

[37]  Run Yu,et al.  Homozygous P86S Mutation of the Human Glucagon Receptor Is Associated With Hyperglucagonemia, &agr; Cell Hyperplasia, and Islet Cell Tumor , 2009, Pancreas.

[38]  M S German,et al.  Mice lacking the homeodomain transcription factor Nkx2.2 have diabetes due to arrested differentiation of pancreatic beta cells. , 1998, Development.

[39]  Andrea Frilling,et al.  Identification of osteopontin as the most consistently over-expressed gene in intrahepatic cholangiocarcinoma: detection by oligonucleotide microarray and real-time PCR analysis. , 2008, World journal of gastroenterology.

[40]  Rameen Beroukhim,et al.  Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. , 2013, Gastroenterology.

[41]  K. Takasaki,et al.  Lymph node metastasis in intrahepatic cholangiocarcinoma. , 1999, Japanese journal of clinical oncology.

[42]  K J Millen,et al.  The ZIC gene family in development and disease , 2005, Clinical genetics.

[43]  Hui Yu,et al.  Link-based quantitative methods to identify differentially coexpressed genes and gene Pairs , 2011, BMC Bioinformatics.

[44]  Homin K. Lee,et al.  Coexpression analysis of human genes across many microarray data sets. , 2004, Genome research.

[45]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[46]  Alexander G Bassuk,et al.  FOXC1 is required for normal cerebellar development and is a major contributor to chromosome 6p25.3 Dandy-Walker malformation , 2009, Nature Genetics.

[47]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[48]  Michael Gregor,et al.  Serum and bile markers for cholangiocarcinoma. , 2004, Seminars in liver disease.

[49]  Sopit Wongkham,et al.  Proteomic Studies of Cholangiocarcinoma and Hepatocellular Carcinoma Cell Secretomes , 2009, Journal of biomedicine & biotechnology.

[50]  P. Nijweide,et al.  Identification of osteopontin in isolated rabbit osteoclasts. , 1992, Biochemical and biophysical research communications.

[51]  C. Cooper,et al.  Mechanisms of Disease: biomarkers and molecular targets from microarray gene expression studies in prostate cancer , 2007, Nature Clinical Practice Urology.

[52]  G. Velho,et al.  A missense mutation in the glucagon receptor gene is associated with non–insulin–dependent diabetes mellitus , 1995, Nature Genetics.

[53]  J. Growdon,et al.  Molecular markers of early Parkinson's disease based on gene expression in blood , 2007, Proceedings of the National Academy of Sciences.